Exploiting new tools for biomedical discovery
Scientists at the FMI pursue basic biomedical research, making use of

genetic approaches in model organisms
detailed proteomic and genomic analyses
quantitative and live fluorescence imaging
structure determination
in their studies of the mechanisms of cancer, epigenetics and neurobiology.
The FMI has established cutting-edge technology platforms that develop and exploit new tools for research, placing FMI scientists at the forefront of biomedical discovery.

Coupling academic research and biomedical application
Affiliated with the Novartis Institutes for BioMedical Research and as an affiliated institute of the University of Basel, the FMI is situated at the interface of academic research and biomedical application. Findings are published and presented to the scientific community, contributing to the collective understanding of human disease. Through collaborative efforts with Novartis, FMI scientists also contribute to the development of both diagnostics and medicines.
FMI students and postdoctoral fellows are not only exposed to the latest in molecular and genetic approaches, but are constantly encouraged to examine the biomedical application of their discoveries.

Encouraging intellectually daring approaches
FMI provides an open, collegial environment for research and encourages the exploration of novel areas with innovative approaches. Our scientists aim to continually push back the horizons of knowledge with original ideas and techniques. Interdisciplinary collaborations and cross-feeding from one field to another occur daily at the FMI.
This tradition allows FMI scientists to play a leading role amongst the many institutes engaged in biomedical research.